These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2701673)

  • 21. What time of day do patients take steroid tablets?
    Partridge MR; Partridge JS; Rooney M; Kava T
    Respir Med; 2001 Jan; 95(1):90-1. PubMed ID: 11207025
    [No Abstract]   [Full Text] [Related]  

  • 22. Exogenous and endogenous glucocorticoids in rheumatic diseases.
    Buttgereit F; Burmester GR; Straub RH; Seibel MJ; Zhou H
    Arthritis Rheum; 2011 Jan; 63(1):1-9. PubMed ID: 20936628
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk factors for infection in patients with remitted rheumatic diseases treated with glucocorticoids.
    Matsumoto Y; Sada KE; Takano M; Toyota N; Yamanaka R; Sugiyama K; Wakabayashi H; Kawabata T; Otsuka F; Makino H
    Acta Med Okayama; 2011 Oct; 65(5):329-34. PubMed ID: 22037270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucocorticoids in rheumatology].
    Dziurla R; Buttgereit F
    Z Rheumatol; 2008 Nov; 67(7):583-91; quiz 592. PubMed ID: 18972122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose glucocorticoids in rheumatic diseases: introduction.
    Pincus T; Bijlsma JW; Braun J; Buttgereit F; Cutolo M
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S2-4. PubMed ID: 22018176
    [No Abstract]   [Full Text] [Related]  

  • 26. Developments in glucocorticoid therapy.
    Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
    Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases.
    Huber BM; Bolt IB; Sauvain MJ; Flück CE
    Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Series on pharmacology in practice. 9. Glucocorticoids in rheumatic disease.
    Nelson AM; Conn DL
    Mayo Clin Proc; 1980 Dec; 55(12):758-69. PubMed ID: 7012460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone: an "old new" glucocorticoid on the horizon!
    Kroot EJ; Huisman MA
    J Rheumatol; 2006 Jun; 33(6):1201; author reply 1201-2. PubMed ID: 16755673
    [No Abstract]   [Full Text] [Related]  

  • 30. [Systemic therapy with glucocorticoids. Treatment of rheumatic diseases].
    Möller B
    Pharm Unserer Zeit; 2003; 32(4):302-5. PubMed ID: 12899067
    [No Abstract]   [Full Text] [Related]  

  • 31. [Corticosteroids in the treatment of rheumatic diseases].
    Alusík S
    Vnitr Lek; 2000 Apr; 46(4):240-2. PubMed ID: 11227178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucocorticoids in the therapy of rheumatism. 2: Systemic corticoid therapy].
    Kaiser H
    Fortschr Med; 1998 Dec; 116(34):41-3. PubMed ID: 10024761
    [No Abstract]   [Full Text] [Related]  

  • 33. Problems related to systemic glucocorticoid therapy in children.
    Melo-Gomes JA
    J Rheumatol Suppl; 1993 Apr; 37():35-9. PubMed ID: 8501750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Side effects" in cortisone therapy].
    Jesserer H
    Acta Med Austriaca; 1975; 2(4):113-6. PubMed ID: 1083614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of glucocorticoids - clinical trials.
    Da Silva JA
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S99-103. PubMed ID: 22018193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special issue on glucocorticoid therapy in rheumatic diseases: introduction.
    Cutolo M; Chrousos GP; Pincus T
    Neuroimmunomodulation; 2015; 22(1-2):3-5. PubMed ID: 25227248
    [No Abstract]   [Full Text] [Related]  

  • 37. Corticosteroid-induced suppression of the cerebro-hypothalamo-pituitary-adrenal axis.
    Nuki G; Downie WW
    Mod Trends Rheumatol; 1971; 2():199-239. PubMed ID: 4344786
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucocorticoids in patients with rheumatic diseases: friends or enemies of bone?
    Ciccarelli F; De Martinis M; Ginaldi L
    Curr Med Chem; 2015; 22(5):596-603. PubMed ID: 25386817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying risks: the case between glucocorticoids and tuberculosis.
    Carmona L
    Arthritis Rheum; 2006 Feb; 55(1):1-2. PubMed ID: 16463392
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonates in patients with glucocorticoids: time for implementation.
    Lems WF
    J Rheumatol; 2009 Aug; 36(8):1570-2. PubMed ID: 19671808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.